Investment
Features
FeesSafety
Academy
More
Pluang+

Granada Gold Mine names J.W. Dumont President to lead exploration and staged development plans.

Company Fundamentals
28 Sep 2026
TheNewswire
View Source
Bullish
Granada Gold Mine names J.W. Dumont President to lead exploration and staged development plans.

Granada Gold Mine Inc. appointed J.W. Dumont as President to oversee financing, exploration, and staged development of its 100%-owned Granada Gold Project in Québec. Dumont brings extensive finance and operational experience in gold mining, aiming to expand resources and advance technical and economic assessments, including a proposed on-site gravity-concentration facility. His role includes securing financing, managing investor relations, and guiding the company through bulk sampling and feasibility studies to support future development stages. This leadership change aims to strengthen Granada's growth strategy and prepare for potential revenue generation while maintaining financial discipline and shareholder value.

Granada Gold Mine's leadership update is presented here with Pluang's Basic Materials sector data for context. Of 38 US Basic Materials stocks priced on Pluang, 8 rose and 29 fell. Notable prices and changes include AEM at USD 183.51 with a -5.64% change, EXK at USD 8.95 with a -4.74% change, and MP at USD 46.55 with a -4.67% change. This snapshot is as of Sep 29, 2026 03:21 WIB.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
1 hour ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
1 hour ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
2 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
2 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App